<img src="https://ml.globenewswire.com/Resource/Download/f7659070-cc55-4e68-ae70-33013e7df72c?size=2" nborder="0" align="left" hspace="5" vspace="5" title="liquidia-new-logo.png" alt="Liquidia Technologies, Inc."/>MORRISVILLE, N.C., May 27, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA) today announced that Dr. Roger Jeffs, Chief Executive Officer, and Michael Kaseta, Chief Operating Officer and Chief Financial Officer, will provide an update on the company’s business in a fireside chat at the Jefferies Global Healthcare Conference in New York on Wednesday, June 3, 2026, at 12:45 p.m. ET. Access to this event will be available on the “Investors” page of Liquidia’s website at <a href="https://www.globenewswire.com/Tracker?data=ljLA2Qpp29qIdTW6IHkE5YdKdOQ0a2Zy3T_EIXIkUG-dA03tqyt-ZgqNJmN-l5tZ1KGr5lEu7QC4Mg_qGUosgjpX7unptKfMOv-8eOcoWUmZbAa9R-K463o9Ux99kX8v_J2puyUux9_9pKgIwWr6obYvH-e7bToMnWxzaxEctCt_QvAD95nI3eDvYFtq17F4" rel="nofollow" target="_blank" title="">https://liquidia.com/investors/events-and-presentations</a>. A replay of the webcast will be archived on the company’s website for at least 30 days. About Liquidia Corporation Liquidia Corporation is a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases through precise, innovative therapies and applications of its proprietary PRINT® technology. PRINT enabled the development of YUTREPIA® (treprostinil) inhalation powder for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company is also developing L606, an investigational extended-release formulation of treprostinil administered twice daily with a next-generation nebulizer and currently markets generic Treprostinil Injection for the treatment of PAH. To learn more about Liquidia, please visit <a href="https://www.globenewswire.com/Tracker?data=EFDjUSD_ntbqy5uyl7qgbs1ypOmeyjEot5nMpQOxAO2asNGEHF95xWqsuw8GE1WrZDaIAsS_UBk68adOTtuSgIxe86il7d2dT6NuLVX9CtQ=" rel="nofollow" target="_blank" title="www.liquidia.com">www.liquidia.com</a>. Investors: Jason Adair Chief Business Officer 919.328.4350 <a href="https://www.globenewswire.com/Tracker?data=DUeUSPfjPg0zSP2ksyfER0JczybYLEJIybqFP565J_flAjBldyvp1Rk2FhPKFRBpLx6aRMTx099ahX63h0yBib2itEyXAPCPW3pQG1aZ8_zW3CnmW9VaGMWmFjymyuGc" rel="nofollow" target="_blank" title="jason.adair@liquidia.com">jason.adair@liquidia.com</a> Media: <a href="https://www.globenewswire.com/Tracker?data=-pQSVQMNlx4AngJZtQBvLEBwfOAvPfAYMEMG7TQUp2X13L2G8aknVuOorL8hTh951pZL8PkS9z0B35rxhbIw9K2AUvsrXmJK01buoGSdgGE=" rel="nofollow" target="_blank" title="media@liquidia.com">media@liquidia.com</a> <img alt="" src='https://ml.globenewswire.com/media/NWE0MjhjMmEtZjZmOS00OTRiLThjMTktZjY4N2FkYTIzNGEyLTEwOTYwMzEtMjAyNi0wNS0yNy1lbg==/tiny/Liquidia-Technologies-Inc-.png' referrerpolicy='no-referrer-when-downgrade' />

GlobeNewswire Inc.

Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference

Latest news from the world of business and finance – both local and global

MONEY FM 89.3 is Singapore's first and only Business and Personal Finance station, featuring local and international business and financial news.

MONEY FM 89.3

Discover newsletters from our DJs on LinkedIn